Abstract
There is emerging evidence that glutamatergic system dysfunction might play an important role in the pathophysiology of bipolar depression. This review focuses on the use of glutamate receptor modulators for depression in bipolar disorder.
Cite
CITATION STYLE
APA
McCloud, T. L., Caddy, C., Jochim, J., Rendell, J. M., Diamond, P. R., Shuttleworth, C., … Cipriani, A. (2016). Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. BJPsych Advances, 22(4), 215–215. https://doi.org/10.1192/apt.22.4.215
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free